The briefing
UCI Health has launched the world’s first in-human clinical trial using embryonic stem cell–derived therapy for Huntington’s disease. The early-phase study will evaluate safety and explore whether the approach could help address neurodegeneration in affected patients.
Original headline
UCI Health launches world's first embryonic stem cell trial for Huntington's disease